Urinary glycosidases as markers of renal dysfunction in patients with cirrhosis.

被引:0
|
作者
Johnston, DE [1 ]
Choi, HJJ [1 ]
Arora, S [1 ]
Fry, D [1 ]
Glew, RH [1 ]
机构
[1] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1685
引用
收藏
页码:582A / 582A
页数:1
相关论文
共 50 条
  • [41] Terlipressin for renal failure in cirrhosis. A single centre review
    Triantos, CK
    Samonakis, DN
    Thalheimer, U
    Cholongitas, E
    Senzolo, M
    Stigliano, R
    Leandro, G
    Patch, D
    Burroughs, AK
    HEPATOLOGY, 2004, 40 (04) : 646A - 646A
  • [42] Adverse renal and hemodynamic effects of β blockers and nitrates in cirrhosis.
    Vuillemin, E
    Oberti, F
    Pillette, C
    Calès, P
    HEPATOLOGY, 1998, 28 (04) : 553A - 553A
  • [43] Evidence for altered renal blood flow autoregulation in cirrhosis.
    Jalan, R
    Mookerjee, RP
    Hayes, PC
    Redhead, DN
    Moore, KP
    Williams, R
    HEPATOLOGY, 2003, 38 (04) : 416A - 417A
  • [44] Albumin dysfunction correlates with disease markers in patients with decompensared cirrhosis
    Horrillo, Raquel
    Mestre, Anna
    Ortiz, Ana Maria
    Perez, Alba
    Raventos, Aida
    Torres, Mireia
    Paez, Antonio
    Arroyo, Vicente
    Fernandez, Javier
    Claria, Joan
    Willis, Todd
    Costa, Montserrat
    JOURNAL OF HEPATOLOGY, 2021, 75 : S354 - S354
  • [45] Surgical treatment of hepatocellular carcinoma in patients with cirrhosis.
    Soubrane, O
    SEMAINE DES HOPITAUX, 1996, 72 (21-22): : 647 - 649
  • [46] Pathophysiology of renal dysfunction in cirrhosis
    Ginès, P
    Sort, P
    DIGESTION, 1998, 59 : 11 - 15
  • [47] The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
    Rios, R
    Sangro, B
    Herrero, I
    Quiroga, J
    Prieto, J
    HEPATOLOGY, 2002, 36 (04) : 520A - 520A
  • [48] Prediction of esophageal varices (EV) in patients with cirrhosis.
    Madhotra, R
    Mulcahy, H
    Willner, IR
    Reuben, A
    GASTROENTEROLOGY, 2000, 118 (04) : A1465 - A1465
  • [49] Fracture risk of patients with primary biliary cirrhosis.
    Boulton-Jones, JR
    Fenn, R
    West, J
    Logan, R
    Ryder, S
    HEPATOLOGY, 2001, 34 (04) : 525A - 525A
  • [50] RISK FACTORS FOR HEPATOCELLULAR CANCER IN PATIENTS WITH CIRRHOSIS.
    Kanwal, Fasiha
    Khaderi, Saira Aijaz
    Singal, Amit G.
    Marrero, Jorge A.
    Loo, Nicole M.
    Asrani, Sumeet K.
    Amos, Chris
    Thrift, Aaron P.
    White, Donna
    Gu, Xiangjun
    Luster, Michelle
    Alsarraj, Abeer
    Ning, Jing
    El-Serag, Hashem B.
    HEPATOLOGY, 2021, 74 : 668A - 668A